TY  - JOUR
AU  - Ayerbe-Algaba, Rafael
AU  - Gil-Marqués, María Luisa
AU  - Jiménez-Mejías, Manuel Enrique
AU  - Sánchez-Encinales, Viviana
AU  - Parra-Millán, Raquel
AU  - Pachón-Ibáñez, María Eugenia
AU  - Pachón, Jerónimo
AU  - Smani, Younes
PY  - 2018
DO  - 10.3389/fcimb.2018.00348
UR  - http://hdl.handle.net/10668/13106
T2  - Frontiers in cellular and infection microbiology
AB  - Colistin is among the few antibiotics effective against multidrug-resistant Acinetobacter baumannii and Klebsiella pneumoniae clinical isolates. However, in the last few years, colistin-resistant A. baumannii and K. pneumoniae strains have emerged....
LA  - en
KW  - Acinetobacter baumannii
KW  - Klebsiella pneumoniae
KW  - colistin
KW  - niclosamide
KW  - repurposing drug
KW  - synergistic effect
KW  - Acinetobacter baumannii
KW  - Anti-Bacterial Agents
KW  - Colistin
KW  - Drug Synergism
KW  - Klebsiella pneumoniae
KW  - Microbial Sensitivity Tests
KW  - Microbial Viability
KW  - Niclosamide
TI  - Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.
TY  - research article
VL  - 8
ER  -